Spire Wealth Management - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Spire Wealth Management ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,247
+16.5%
2,091
+45.1%
0.00%0.0%
Q2 2023$13,949
-11.7%
1,4410.0%0.00%0.0%
Q1 2023$15,793
+263116.7%
1,4410.0%0.00%
Q4 2022$6
-99.9%
1,4410.0%0.00%
-100.0%
Q3 2022$11,000
-42.1%
1,441
-21.7%
0.00%0.0%
Q2 2022$19,000
-17.4%
1,8410.0%0.00%0.0%
Q1 2022$23,000
-46.5%
1,841
-1.1%
0.00%0.0%
Q4 2021$43,000
+26.5%
1,861
+20.8%
0.00%0.0%
Q3 2021$34,000
+70.0%
1,5410.0%0.00%0.0%
Q2 2021$20,000
+17.6%
1,541
+18.1%
0.00%
Q1 2021$17,0001,3050.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders